NCT02039674
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,258 public trials
1,193 recruiting studies
Carcinoma, Bronchogenic trial results
Completed
Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis
NCT00890617
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT02066636
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Southern Cancer Center Pc Mobile, Alabama, United States
- Cancer Center Treatment Center of America Goodyear, Arizona, United States
- Arizona Oncology Associates Phoenix, Arizona, United States
- Arizona Oncology Associates Sedona, Arizona, United States
NCT03900117
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Hui Liu Guangzhou, Guangdong, China
NCT02835690
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
NCT02728596
- Conditions
- Agranulocytosis, Breast Carcinoma In Situ, Breast Diseases, +60 more
- Locations
-
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
- Contra Costa Regional Medical Center Martinez, California, United States
- Augusta University Medical Center Augusta, Georgia, United States
NCT02357992
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00199849
- Conditions
- Bladder Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +35 more
- Locations
-
- New York Presbyterian Hospital New York, United States
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer
NCT02898116
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Research Facility New York, United States
NCT03164772
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Research Facility Gilbert, Arizona, United States
- Research Facility Tampa, Florida, United States
- Research Facility Detroit, Michigan, United States
- Research Facility New York, United States